Amber Therapeutics
UK - London
BiotechnologyFocus: Neuromodulation Therapy
Amber Therapeutics is a life sciences company focused on Neuromodulation Therapy.
UnknownOphthalmology
Funding Stage
PUBLIC
Open Jobs
3
Pipeline & Clinical Trials
VCFix Spinal System in stand-alone configuration
Vertebral Compression FractureClinical Trials (1)
NCT07301749A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures.
N/ARetrospective cohort
Conscious SedationClinical Trials (1)
NCT04172415Current Procedural Sedation Practices in a Canadian Community Emergency Department
N/APicostim Amber
Overactive BladderClinical Trials (1)
NCT05256498AURA 1: Augmenting Urinary Reflex Activity: Study 1
N/AAmber UI System
Overactive BladderClinical Trials (1)
NCT05241379AURA-2: Augmenting Urinary Reflex Activity
N/APudendal neuromodulation
Mixed Urinary IncontinenceClinical Trials (1)
NCT06885931Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
N/AVCFix Spinal System in stand-alone configuration
Vertebral Compression FractureClinical Trials (1)
NCT07259811Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration
N/AAmber UI system
Urinary IncontinenceClinical Trials (1)
NCT06597994Augmenting Urinary Reflex Activity: Study 3
N/AGrass pollen extract
Allergic RhinitisClinical Trials (1)
NCT01982474Safety of Lymph Node Injection for Allergen Immunotherapy
Phase 1Nexagon®
Corneal Persistent Epithelial DefectClinical Trials (1)
NCT04081103NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Phase 2Open Jobs (3)
Interview Prep Quick Facts
Founded: 2021
Portfolio: 9 clinical trials
Open Roles: 3 active jobs